Pharmaceutical companies, along with other manufacturing companies, have felt the impact of the COVID-19 pandemic. Disrupted supply chains and rising commodity prices require a joint strategy with the state to reduce the risks of rising drug prices in the domestic market, but also to stimulate domestic consumption of local products.
This and other topics were addressed during the informal meeting of ICS Eurofarmaco SA with FIA Executive Director, Ms. Ana Groza, organized by the Association with its members to update the interaction agenda between foreign investors and the Government of Moldova, but also to mitigate the impact of the pandemic on the economy and the business environment.